MarketPulse — Real-Time Financial News & Market Analysis

Sumitomo Forestry acquires Tri Pointe Homes for $4.5 billion in all-cash deal, expanding U.S. residential construction presence with plans for 23,000 annual homes by 2030.

U.S. equities fell sharply Thursday amid $22 billion in settlement activity, with S&P 500 down 1.6% and NASDAQ 100 down 2%. Additional settlements ahead could amplify volatility.

Alphabet shows strong momentum with Google Cloud growing 48%, AI cost cuts of 78%, and $164.7B operating cash flow, positioning it as diversified tech cornerstone.

Elkem's Q4 earnings fell 24% amid weak markets, but cost controls helped. Company divests Silicones division to Bluestar, skipping dividends due to equity impact.

Beyond Meat faces shareholder class action over alleged undisclosed asset impairment charges. Investors who bought stock Feb-Nov 2025 can join litigation by March 24, 2026.

Rivian launches mass-market R2 truck in 2026 with $7B cash reserves, but faces EV market headwinds and fierce competition testing profitability prospects.

Schall Law Firm launches class action against Charming Medical (MCTA) after SEC suspended trading following alleged market manipulation through social media promotion.

Norsk Hydro's board recommends NOK 3.0 per share dividend from 2025 results, pending shareholder approval at May 2026 meeting with payment planned for May 19.

Global chemical distribution market projected to double from $271B in 2025 to $467B by 2033, driven by strong demand across agriculture, pharma, and automotive sectors.

EV sales slumped globally in January 2026 as policy shifts triggered sharp declines in China and US, though Europe and emerging markets showed resilience.

Palantir posts strong 70% revenue growth and 250% net income surge, but sky-high valuation metrics leave little room for any growth slowdown.

Class action filed against Charming Medical for alleged stock price manipulation through coordinated social media promotion. Trading suspended pending SEC investigation.

Tesla stock down 5% YTD after missing Q4 targets with 16% delivery decline. Company pivots to unproven autonomous and robotics ventures amid high valuation pressures.

Tilray Pharma partners with Smartway Pharmaceuticals to expand UK drug distribution, combining their networks to strengthen presence in Britain's £1 billion pharma market.

Tilray expands UK pharmaceutical distribution via CC Pharma's partnership with Smartway Pharmaceuticals, combining distribution networks and manufacturing expertise to serve the £1 billion market.

OKYO Pharma prices $20M share offering to fund clinical development of urcosimod for neuropathic corneal pain treatment, advancing Phase 2b/3 trial.

Ultragenyx faces securities lawsuit alleging misleading claims about setrusumab's efficacy. Investors must act by April 6, 2026 deadline to join class action.

VCI Global files subsidiary IPO to advance AI-native strategy. V Capital Consulting seeks Nasdaq listing as parent company pivots to AI-focused operations.

VCI Global pursues AI-native strategy while spinning off consulting subsidiary VCCG, which filed for Nasdaq listing. Parent company focuses on robotics, clean energy, and automotive technologies.

Amazon and CrowdStrike identified as strong long-term tech investments. Amazon dominates cloud computing; CrowdStrike leads in AI-driven cybersecurity solutions.